LIMD2 Regulates Key Steps of Metastasis Cascade in Papillary Thyroid Cancer Cells via MAPK Crosstalk
暂无分享,去创建一个
F. Rauscher | Hongzhuang Peng | S. Bydlowski | J. Cerutti | R. P. Araldi | Thatiana Corrêa de Melo | G. A. Colozza-Gama | D. Levy | Dener Madeiro de Souza | B. Maurício
[1] Gong Yang,et al. The crosstalk between STAT3 and p53/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT and autophagy , 2019, Oncogenesis.
[2] S. Qin,et al. Overexpression of LIMD2 promotes the progression of non-small cell lung cancer. , 2019, Oncology letters.
[3] C. Korch,et al. Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies , 2019, Clinical Cancer Research.
[4] Qing‐Yu He,et al. Significance of integrin-linked kinase (ILK) in tumorigenesis and its potential implication as a biomarker and therapeutic target for human cancer. , 2019, American journal of cancer research.
[5] M. Schlumberger,et al. Occult Contralateral Lateral Lymph Node Metastases in Unilateral N1b Papillary Thyroid Carcinoma , 2018, World Journal of Surgery.
[6] Fei Wang,et al. LIMD2 targeted by miR‑34a promotes the proliferation and invasion of non‑small cell lung cancer cells. , 2018, Molecular medicine reports.
[7] B. Jakovljević,et al. Lymph Node Metastases Papillary Thyroid Carcinoma and their Importance in Recurrence of Disease , 2018, Medical archives.
[8] F. Rauscher,et al. LIMD2 Is Overexpressed in BRAF V600E-Positive Papillary Thyroid Carcinomas and Matched Lymph Node Metastases , 2018, Endocrine Pathology.
[9] J. Cerutti,et al. Novel biotechnological opportunities in thyroid cancer metastasis based on LIMD2 differential expression , 2018 .
[10] J. Cerutti,et al. ABI3, a component of the WAVE2 complex, is potentially regulated by PI3K/AKT pathway , 2017, Oncotarget.
[11] Nancy D Perrier,et al. Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why? , 2017, Thyroid : official journal of the American Thyroid Association.
[12] Chen Huang,et al. Regulation of EMT by STAT3 in gastrointestinal cancer (Review). , 2017, International journal of oncology.
[13] Kevin W. Eliceiri,et al. ImageJ2: ImageJ for the next generation of scientific image data , 2017, BMC Bioinformatics.
[14] Kaliszewski,et al. American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer , 2017 .
[15] S. Mandel,et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.
[16] M. Saji,et al. Integrin-linked kinase affects signaling pathways and migration in thyroid cancer cells and is a potential therapeutic target. , 2016, Surgery.
[17] R. Franco,et al. Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8–Akt–Slug pathway , 2015, Oncogene.
[18] Anders Larsson,et al. AliView: a fast and lightweight alignment viewer and editor for large datasets , 2014, Bioinform..
[19] Qihong Huang,et al. LIMD2 is a small LIM-only protein overexpressed in metastatic lesions that regulates cell motility and tumor progression by directly binding to and activating the integrin-linked kinase. , 2014, Cancer research.
[20] Xuelin Huang,et al. An improvement of the 2ˆ(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. , 2013, Biostatistics, bioinformatics and biomathematics.
[21] S. Bhatia,et al. Mitochondrial localization and the persistent migration of epithelial cancer cells. , 2013, Biophysical journal.
[22] R. Lloyd,et al. Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas , 2013, Modern Pathology.
[23] A. Baxevanis,et al. The Diversification of the LIM Superclass at the Base of the Metazoa Increased Subcellular Complexity and Promoted Multicellular Specialization , 2012, PloS one.
[24] Alexandru Almasan,et al. Histone H2AX phosphorylation: a marker for DNA damage. , 2012, Methods in molecular biology.
[25] R. Maestro,et al. Overexpression of TWIST2 correlates with poor prognosis in Head and Neck Squamous Cell Carcinomas , 2011, OncoTarget.
[26] J. Cerutti,et al. The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo. , 2011, Thyroid : official journal of the American Thyroid Association.
[27] D. Meek,et al. Phosphorylation of serine 392 in p53 is a common and integral event during p53 induction by diverse stimuli. , 2010, Cellular signalling.
[28] T. Hupp,et al. The regulation of p53 by phosphorylation: a model for how distinct signals integrate into the p53 pathway , 2009, Aging.
[29] B. Olsen,et al. Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. , 2008, Molecular biology of the cell.
[30] G. Riggins,et al. Molecular profiling of matched samples identifies biomarkers of papillary thyroid carcinoma lymph node metastasis. , 2007, Cancer research.
[31] A. Chrisoulidou,et al. Cerebellar metastasis as first metastasis from papillary thyroid carcinoma. , 2005, Endocrine journal.
[32] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[33] F. Hirsch,et al. The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. , 2002, Lung cancer.
[34] E. Fearon,et al. The SLUG zinc-finger protein represses E-cadherin in breast cancer. , 2002, Cancer research.
[35] Eric R. Fearon,et al. Advances in Brief The SLUG Zinc-Finger Protein Represses E-Cadherin in Breast Cancer 1 , 2002 .
[36] M. Ranney,et al. Beyond the bedside: Clinicians as guardians of public health, medicine and science , 2020, The American Journal of Emergency Medicine.